Viewing Study NCT00045032


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2025-12-25 @ 7:25 PM
Study NCT ID: NCT00045032
Status: COMPLETED
Last Update Posted: 2017-04-27
First Post: 2002-09-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
Sponsor:
Organization: